Guidance

Summary of changes

Updated 21 May 2024

© Crown copyright 2024

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/guidance-on-the-microbiological-safety-of-human-organs-tissues-and-cells-used-in-transplantation/summary-of-changes

This guidance was previously known as ‘Guidance on the microbiological safety of human organs, tissues and cells used in transplantation’.

Current version: 2.2, revised July 2023

Summary of changes from version 1.0 published January 2018

Version 2.0

Version 2.0 was revised by Mr Chris Callaghan and other members of SaBTO, January 2020.

Changes were:

  • addition of a new annex to cover SARS-CoV-2
  • addition of the effects of cryopreservation on toxoplasma gondii in section 12
  • addition of hepatitis B testing for non-partner gamete donors testing in table 7

Version 2.1

Version 2.1 was revised by Mr Chris Callaghan and other members of SaBTO, January 2023.

Changes were:

  • addition of a footnote to ‘Legislation and accountability’ to include the changes to UK legislation since the UK left the EU in 2021
  • clarification on who should provide expert guidance on the interpretation of microbiological results in section 9
  • addition of monkeypox (Mpox) to section 13
  • updated residual risk estimates in table 4

Version 2.2

Version 2.2 was revised by Mr Chris Callaghan, Dr Ines Ushiro-Lumb and members of SaBTO, July 2023.

Changes were:

  • update on Mpox to section 13
  • update to malaria to section 13
  • addition of section on human herpes virus (HHV-8), in the context of introduction of screening for HHV-8 in deceased organ donors, section 12.23
  • updates to table 3
Back to top